Stage II Melanoma
Stage II melanoma is a type of skin cancer where the tumor is thicker and may have spread to nearby lymph nodes but not to distant sites. Early detection and treatment are crucial for better outcomes.
Melanoma: Ipilimumab and Nivolumab Combination
We are testing a new treatment using two immunotherapy drugs for patients with high-risk stage II melanoma. The goal is to see if this combination can improve outcomes before surgery.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Tuebingen AöR
Department of Dermatology
Tübingen, Germany
Amsterdam UMC
Medical Oncology
Amstelveen, Netherlands
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Medical Oncology
Amstelveen, Netherlands
Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.